Author: Daily Upsider

A forthcoming vaccine for Lyme disease is undergoing its final clinical trial, announced by French pharmaceutical company Valneva, in collaboration with Pfizer. This vaccine, dubbed VLA5, demonstrated a robust immune response during Phase 2 trials.

The upcoming Phase 3 trial will enlist 6,000 participants worldwide, focusing on regions with high Lyme disease prevalence such as Finland, Germany, the Netherlands, Poland, Sweden, and the United States. By targeting the outer surface protein (OspA) of the Borrelia burgdorferi bacteria transmitted by ticks, the vaccine aims to prevent human infection.

Annaliesa Anderson, Ph.D., Senior Vice President and Head of Vaccine Research & Development at Pfizer, expressed anticipation for the Phase 3 results, emphasizing collaboration with research sites in the U.S. and Europe.

With over 476,000 annual Lyme disease cases in the U.S. and a 5.8 percent global incidence rate, the potential impact of this vaccine is substantial. Given Lyme disease’s capacity to progress into chronic illness, the prospect of preventing debilitating conditions for millions is a significant development.

Lootah Biofuels, a Dubai-based company, is producing biodiesel from used cooking oil, introducing a fascinating new sustainable transportation solution.

This initiative results in a cost-effective, renewable, and environmentally friendly fuel alternative. The company has expanded its presence with fuel outlets across Dubai, with an annual production capacity of 60 million liters.

Yousif Bin Saeed Al Lootah conceptualized this project with the aim of making the UAE the first nation in the region to require biofuel blends at public fuel stations.

By offering payment for collected used cooking oil, Lootah Biofuels incentivizes providers such as restaurants, bakeries, and food chains, who contribute 500,000 liters of waste oil monthly.

Last year, the company converted this waste oil into 770 tons of biofuel.

According to the Lootah Biofuels website, used cooking oil boasts the highest carbon saving ratio among all biodiesel feedstocks, resulting in an estimated reduction of 500 million tons of CO2 emissions to date.

Joy Milne, a retired nurse from Perth, Scotland, possesses the remarkable ability to detect Parkinson’s disease through smell. Her husband exhibited an unusual odor around his shoulders and neck long before his formal diagnosis.

This later led Joy to recognize the distinct smells association with the condition when she later identified the same scent at a Parkinson’s support group. This unique skill caught the attention of scientists, prompting the development of a skin swab test by researchers at Manchester University.

The test, which analyzes sebum from the patient’s back, demonstrated an impressive 95% accuracy in trials. Researchers identified 500 different compounds in the sebum samples, differentiating those with Parkinson’s from the control group. Currently, no chemical test exists for Parkinson’s, resulting in lengthy waiting lists for neurological consultations.

Professor Perdita Barran, leading the research, envisions the potential for these tests to be implemented in general practitioners’ offices, offering quick diagnoses within three minutes. Efforts are underway to transition the test from research labs to hospital analytical labs, with hopes to begin testing individuals in the Manchester area within two years.

The fact that Joy can smell Parkinson’s is rather shocking. The fact that they have used that to help create a whole new type of test is just incredible.